People · Operator
Named in public records as an officer, director or promoter · active 2008–2022 · Biotechnology, Other, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Reshape Medical, Inc. | — | Biotechnology | Series B | $75.1M | $436.6M | 2012 |
| Foldax, Inc. | — | Other | Series A | $38.7M | $39.4M | 2022 |
| Compellon Inc | — | Other Technology | Series A | $10.1M | $9.7M | 2012 |
| Orqis Medical Corp | — | Other Health Care | Seed | $1.2M | $29.6M | 2008 |
Kenneth Charhut at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kenneth Charhut on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| George Wallace | 2 | 8 |
| James Demetriades | 2 | 4 |
| Richard Thompson | 1 | 17 |
| Casey Tansey | 1 | 14 |
| Olav B. Bergheim | 1 | 13 |
| Bruce Feuchter | 1 | 12 |
| Robert Grant | 1 | 12 |
| Brant Heise | 1 | 10 |
| Mark Leschly | 1 | 9 |
| Jeani Delagardelle | 1 | 8 |
| Brian Dovey | 1 | 7 |
| David Milne | 1 | 7 |
| Scott Huennekens | 1 | 7 |
| Morteza Gharib | 1 | 5 |
| JAMES ADOX | 1 | 5 |
| Greg Casciaro | 1 | 4 |
| Renee Masi | 1 | 3 |
| Michael Mashaal | 1 | 3 |
| Ken Charhut | 1 | 3 |
| Mory Gharib | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.